The Role of Nutrigenomics and Population Variability in Nutritional Risk Assessment John Milner Nutritional Science Research Group Division Cancer Prevention, National Cancer Institute milnerj@mail.nih.gov
Biological Determinants of the Response to Bioactive Food Components Absorbed Dose (?) Inactive Metabolite Biologically Effective Dose Molecular Target Dietary Exposure Susceptibility Factors Early Biologic Effect Health Effect + and - Altered Structure/ Function
Relative Risk of Breast Cancer: Influence of Soy Asian Western Lee 92 (total soy protein) p < 0.001 Premenopausal NS Postmenopausal Hirose 95 (bean curd, miso) Yuan 95 (tofu, soymilk) NS Premenopausal NS Postmenopausal NS p = 0.44 0.79 0.79 Shanghai, Tianjin Wu 96 (tofu) p < 0.01 Premenopausal p < 0.05 Postmenopausal Key 99 (soy) Tofu Miso Zheng 99 (urinary isoflavonoids) Dai 01 (soy) NS All Breast Cancer S Just ER + /PR + Wu 02 (soy) Yamamoto 03 (isoflavonoid consumption) Premenopausal Postmenopausal Wu 04 (soy) Ingram 97 (urinary isoflavones) NS Diadzein p = 0.009 Equol Witte 97 (soy) den Tonkelaar 01 (urinary phytoestrogens) NS Postmenopausal Horn-Ross 01 (phytoestrogen intake) Keinan-Boker 02 (food content) NS Isoflavones S Lignans Linseisen 04 (isoflavone intake) daidzein and genistein.1.3.6.46.66.95.25.44.78.6 1.3 2.6.6.8 1.0.61.6.17.47 1.33.1.27.69.2.5 1.1.34.58.98.7 1.0 1.3.78 1.07 1.47.68.87 1.12.18.65 2.37.4.6 1.2.22.48 1.1.25.47.90.36.53.78.46.83 1.3.36.57.83.79 1.0 1.3.79 1.08 1.59 0.5 1 1.5 2
Lots of Variability in Prospective Studies High vs. Low Tomato Intake or Lycopene & Prostate Cancer RR (95% CI) 0.50 0.50 0.60 0.64 0.65 0.75 0.75 0.83 0.79 1.1 1.05 0 0.4 0.8 1.0 1.4 2.2 Mills, 1989 Hsing, 1990 Giovannucci, 1995 Nomura, 1997 Schuurman, 1998 Cerhan, 1998 Gann, 1999 Giovannucci, 2002 Huang, 2003 Huang, 2003 Wu, 2004 plasma-based dietary-based
Individual Consumption of All Tomatoes and Tomato Products and Serum Lycopene Levels (EPIC Cross-sectional Study in 3000 subjects) Intake of all Tomatoes and Tomato Products (g/day, log transformed) 6.0 5.0 4.0 3.0 2.0 1.0 0.0 0.0 1.0 2.0 3.0 4.0 5.0 6.0 Mean Serum Lycopene (microg/dl, log transformed) Jenab et al. J. Nutr. 135:2032, 2005 Corr = 0.23
Nutrigenomics As A Determinant of Response Bioactive Food Component N u t r i g e n o m i c s Nutrigenetics Nutritional Epigenetics Nutritional Transcriptomics DNA RNA Phenotype Protein Proteomics Metabolomics Metabolite Nutritional Preemption Concept that bioactive food components can be introduced at points of initiation & progression for pathway leading to an unhealthy or lethal phenotype. Overall the Omics are understudied
Which of the Many Dietary Components Are Most Important For Evaluating Nutritional Risk? Essential Nutrients- Ca, Zn, Se, Folate, C, E Non-Essential Phytochemicals- Carotenoids, Flavonoids, Indoles, Isothiocyanates, Allyl Sulfur Zoochemicals - Conjugated linoleic acid, n-3 fatty acids Fungochemicals - Several compounds in mushrooms Bacteriochemical - Those formed from food fermentations and those resulting from intestinal flora Unclear How Best to Prioritize Dietary Variables!
Human Genome Establishes Microbial Populations? Bacterial Formed Equol May Account for Part of the Anticancer Properties from Soy in Asian-Americans In addition to genistein microorganisms recently identified in subpopulations form equol which possesses anticancer properties (J Nutr. 2006 Apr;136(4):946-52. Arch Microbiol. 2005;183:45 55). The mechanism by which equol may offer protection remains unresolved. The interrelationships among other microbes, genetics and diet remain to be defined.
Niculescu et al (2006) J Nutr. Biochem demonstrated that isoflavone treatment in subjects who have the capacity to produce equol differentially affects gene expression as compared with nonproducers. Expression of a large number of genes was altered by isoflavone treatment, including induction of genes associated with cyclic adenosine 3,5 -monophosphate (camp) signaling and cell differentiation and decreased expression of genes associated with cyclin-dependent kinase activity and cell division. In general, isoflavones had a stronger effect on some putative estrogen-responsive genes in equol producers than in nonproducers.
Benefits May Surface Once Threshold Exceeded and with Specific Genetic Polymorphism(s) Myeloperoxidase Polymorphism (G463A) and Higher Fruit/Vegetable Intake Breast Cancer Risk Odds Ratio 1 0.5 0.0 0.78 0.63 Risk not related to polymorphism when intakes was low. Low and high consumption based on median values of control group: fruit and vegetable, 29 svg/wk GG GA AA Premenopausal- greatest response to increased fruits and vegetables Ahn et al. Cancer Res. 2004; 64 :7634-9
Genetic Information May Assist in Identifying Those Who Must Achieve Minimum Intakes OR for Colon Cancer 3 2.5 2 1.5 1 0.5 * * Dietary Calcium < 388 mg/day >388 mg/day P for trend=0.004 0 FF Ff ff VDR Genotype Wong et al. Carcinogenesis, 24: 1091-1095, 2003
Genetic Information May Also Identify Those Benefiting Most/Least From Dietary Change Frequency 64% 32% 4% Ordovas et al. (2002) Circulation 106:2315.
Setting An Intake Goal May Decrease Risk in Some But Increase Risk in Others -514(C/T) Ordovas et al. (2002) Circulation 106:2315.
Spine Bone Mass Density (%) Genetic Information May Help Identify Those At Risk and to Formulate Appropriate Interventions 6 0 < 300 mg Caffeine > 300 mg -6-12 TT Tt tt TT Tt tt Vitamin D Receptor Genotype Rapuri et al. Am J Clin Nutr 2001 Nov;74(5):694-700
Not Knowing Genomics Can Cause Misinterpretation Percent survival 100 90 80 70 60 50 40 30 20 10 p21+/+ AIN-76A Diet p21+/- AIN-76A Diet p21+/+ Western Diet p21-/- AIN-76A Diet p21+/- Western Diet p21-/- Western Diet 0 Yang et al, Cancer Res. 61, 565, 2001 0 4 8 12 16 20 24 28 32 36 Weeks
Human Genome: 3,000,000,000 base pairs An analogy - the genome encyclopedia: average 5 letters per word =====> ~600,000,000 words average 12 words per line =====> ~50,000,000 lines average 70 lines per page ======> ~700,000 pages About 30,000 Genes, 8-10 Million SNPs Few Intervention Studies to truly test the importance of SNPs
More than the 4 DNA bases are involved in determining the response epigenetics is also important
What is Epigenetics? The study of heritable changes in gene expression that occur without a change in DNA sequence. DNA methylation Histone posttranslational modifications: Acetylation of lysines Methylation of lysines and arginines Phosphorylations of serines and threonines ADP-ribosylation of glutamic acids Ubiquitination of lysine residues Sumolyation of lysine residues Biotinylation of lysines Recently, in human cells small-interfering RNAs (sirnas) have been shown to mediate transcriptional gene silencing (Morris KV, Cell Mol. Life Sci. 62:3057-3066, 2005).
Issa et al. (2001) Cancer Research 61, 3573-3577
5,10-methylenetetrahydrofolate Reductase (MTHFR) 677C About 50% Caucasians and Asians are heterozygous at 677 codon with modestly impaired methylation capacity About 12% are homozygous with severely impaired methylation capacity Shelnutt et al. (2004) J Nutr Biochem.15:554-60 Graziano et al (2006) Int J Cancer 118:628-32
LTR Hypomethylated When to Intervene?? Maternal Supplements with zinc, methionine betaine, choline, folate, B 12 Or Genistein LTR Hypermethylated Yellow Mouse High risk cancer, diabetes, obesity & reduced lifespan Agouti Mouse Lower risk of cancer, diabetes, obesity and prolonged life Cooney et al. J Nutr 132:2393S (2002); Dolinoy et al. Envir. Health Perspect 114: 567 (2006)
Transcriptomics: Differentially expressed genes in human blood leukocytes after consumption of a high-protein (HP) or highcarbohydrate (HC) breakfast van Erk et al. (2006) Am J Clin Nutr;84:1233-41
Combinations May Influence The Quantity Needed For A Response? Garlic, fish, broccoli Active Intermediate (radical??) keap-1 nrf2 Agent HS SH S S keap-1 Cytoplasm nrf2 small maf ARE nrf2 antioxidant responsive element Nucleus Increased GST, QR
Future Is To Focus on the Process Needing Modification Credentialing of nutrients and molecular targets is likely the future?
Bioactive Food Component N u t r i g e n o m i c s Nutrigenetics Nutritional Epigenetics Nutritional Transcriptomics DNA RNA Protein Cellular Process(es) Proteomics Metabolomics Metabolite Phenotype
Food/Food Components (n-3/butyrate/ Herbs/Spices,) Inflammatory Stimuli (chemicals, ROS, bacteria, viruses) Polymorphisms (Pro- and Anti Inflammatory Genes) Inflammatory Response Disease Morbidity Mortality
K14-HPV16 Transgenic Mouse Background Mouse No Estrogen Normal Diet Estrogen Normal Diet Estrogen Diet + I3C Proliferation Assay: PCNA by immunohistochemistry Auborn et al, Personal Communication
Bioactive Food Component N u t r i g e n o m i c s Nutrigenetics Nutritional Epigenetics Nutritional Transcriptomics DNA RNA Protein Needs & Insults Cellular Process(es) Proteomics Metabolomics Metabolite Phenotype
Amounts and Time of Administration Also Key Factors In Determining Overall Response
Quantity and Intended Use Toxicity Response Antioxidant Carcinogen Metabolism Immune Enhancement Cell Cycle Inhibition Apoptosis Differentiation Exposure Modified from Combs and Gray, Parmacol. Ther. 79: 179-192, 1998.
Even One Dietary Exposure May Create Different Response Depending on Starting Point Total Cancer Incidence 60 50 40 30 20 10 * Selenium Placebo 0 <105.2 105.3- >121.6 121.6 Plasma Selenium (ng/ml) Duffield-Lillico et al., (2002) Cancer, Epidem. Biomarkers & Prev., 11: 630
Combinations Better than Individual Components?? 0 10 Genistein 100 Swami et al. ( 2005) Mol Cell Endocrinol. 241(1-2):49-61.
Linxian Nutrition Intervention Trial Esophageal cancer mortality by factor D (N=1515) Factor D= Selenium, β-carotene, vitamin E <55 years Log-rank P=0.024 RR=0.83 Placebo Factor D 55+ years Log-rank P=0.045 RR=1.14 Factor D Placebo Esophageal Cancer Death Time (Year) Esophageal Cancer Death Time (Year) Taylor, P. et al., Gastroenterology 2005 (abstract)
When I knew all of life s answers, they changed all the questions!
Rests with the: The Future of Nutrigenomics Identification and validation of nutrigenetic, nutritional epigenetic & transcriptomic biomarkers of exposure, effect, & susceptibility and associations with proteomic and metabolomic biomarkers. Effective communication about omics information to the health care community and consumers Ability to work within a responsible bioethical framework